US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine

As fears of a pandemic mount, the biotech company’s mRNA vaccine trial is set to release Phase 1/2 results later this year, with a larger Phase 3 trial expected to begin in 2025. Learn more about your ad choices. Visit podcastchoices.com/adchoices